Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16:589–604
Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68:394–424
Google Scholar
Axley P, Ahmed Z, Ravi S, Singal AK (2018) Hepatitis C virus and hepatocellular carcinoma: a narrative review. J. Clin. Transl. Hepatol. 6:79–84
Article
PubMed
Google Scholar
Hsu SJ, Yang SS, Kao JH (2020) Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: fact or fiction? J. Formos. Med. Assoc 119(Pt 1):3–11.
Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K (2018) Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C. J. Hepatol. 69:1088–1098
Article
PubMed
PubMed Central
Google Scholar
Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK et al (2019) Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores. Gastroenterology 157:1264–1278 e4
Article
CAS
PubMed
Google Scholar
Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C et al (2019) Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 393:1453–1464
Article
CAS
PubMed
Google Scholar
Baumert TF, Juhling F, Ono A, Hoshida Y (2017) Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals. BMC Med. 15:52
Article
PubMed
PubMed Central
Google Scholar
Waziry R, Hajarizadeh B, Grebely J, Amin J, Law M, Danta M et al (2017) Hepatocellularcarcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, andmeta-regression. J. Hepatol. 67:1204–1212
Article
CAS
PubMed
Google Scholar
Capurro M, Filmus J (2005) Glypican-3 as a serum marker for hepatocellular carcinoma. Cancer Res 65(1):372–373
CAS
PubMed
Google Scholar
Hamdy MN, Shaheen KY, Awad MA, Barakat EMF, Shalaby SI, Gupta N et al (2020) Vascular endothelial growth factor (VEGF) as a biochemical marker for the diagnosis of hepatocellular carcinoma (HCC). Clinical Practice. 17(1):1441–1453
Google Scholar
Zhu AX, Duda DG, Sahani DV, Jain RK (2011) HCC and angiogenesis: possible targets and future directions. Nat. Rev. Clin. Oncol. 8:292–301
Article
CAS
PubMed
PubMed Central
Google Scholar
Hassan M, Selimovic D, Ghozlan H, Abdel-kader O (2009) Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 49:1469–1482
Article
CAS
PubMed
Google Scholar
Kanda T, Steele R, Ray R, Ray RB (2008) Hepatitis C virus core protein augments androgen receptor-mediated signaling. J. Virol. 82:11066–11072
Article
CAS
PubMed
PubMed Central
Google Scholar
Mukozu T, Nagal H, Matsui D, Kanekawa T, Sumino Y (2013) Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma. ANTICANCER RESEARCH. 33:1013–1022
PubMed
Google Scholar
Villani R, Facciorusso A, Bellanti F, Tamborra R, Piscazzi A, Landriscina M et al (2016) DAAs rapidly reduce inflammation but increase serum VEGF level: a rationale for tumor risk during anti-HCV treatment. PLoS ONE. 11(12):e0167934
Article
PubMed
PubMed Central
Google Scholar
Roche B, Coilly A, Duclos-Vallee JC, Samuel D (2018) The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Liver Int. 38(1):130–145
Google Scholar
Debes JD, Tilborg MV, Groothuismink ZMA, Hansen BE, Wiesch JSZ, Felden JV et al (2018) Levels of cytokines in serum associate with development of hepatocellular carcinoma in patients with HCV infection treated with direct-acting antivirals. Gastroenterology. 154(3):515–517
Article
CAS
PubMed
Google Scholar
Faillaci F, Marzi L, Critelli R, Milosa F, Schepis F, Turola E et al (2018) Liver angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after hepatitis C virus direct-acting antivirals. Hepatology. 68(3):1010–1024
Article
CAS
PubMed
Google Scholar
Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N (1988) Low serum creatinine levels in severe hepatic disease. Arch Intern Med. 148:1313–1315
Article
CAS
PubMed
Google Scholar
Cheung MCM, Walker AJ, Hudson BE, Verma S, McLauchlan J, David J, Mutimer DJ et al (2016) Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol. 65(4):741–747
Article
CAS
PubMed
Google Scholar
Nalesnik MA, Michalopoulos GK (2012) Growth factor pathways in development and progression of hepatocellular carcinoma. Front Biosci (School Educ) 4:1487–1515
Article
Google Scholar
Carr BI, Guerra V (2013) Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci. 58(6):1790–1796
Article
PubMed
PubMed Central
Google Scholar
Zhang J, Chen G, Zhang P, Zhang J, Li X, Gan D et al (2020) The threshold of alphafetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. PLoS ONE 15(2):e0228857
Article
CAS
PubMed
PubMed Central
Google Scholar
Divella R, Mazzocca A, Daniele A, Sabbà C, Paradiso A (2019) Obesity, non-alcoholic fatty liver disease and adipocytokines network in promotion of cancer. Int J Biol Sci. 15(3):610–616
Article
CAS
PubMed
PubMed Central
Google Scholar
Shariff MI, Gomaa AI, Cox IJ, Patel M, Williams HR, Crossey MM et al (2011) Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res. 10:1828–1836
Article
CAS
PubMed
Google Scholar
Carr BI, Guerra V (2017) Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients. Int J Biol Markers 32(4):e391–e396
Article
PubMed
Google Scholar
Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM (2013) Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 144(3):512–527
Article
PubMed
Google Scholar
Schütte K, Tippelt B, Schulz C (2015) Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr. 34:1122–1127
Article
PubMed
Google Scholar
Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL et al (2014) Association of abnormal plasma bilirubin with aggressive HCC phenotype. Semin Oncol. 41(2):252–258
Article
CAS
PubMed
PubMed Central
Google Scholar